Username Password
S&P 500: 2,076.78
Change: -0.03%

MEDIVATION INC. (MDVN)

Overview
Price 112.31
Price Change Today -$0.82 (-0.72%)
P&P rating Rating: 2
Open Price $113.47
Previous Close $113.13
Daily Range $111.41 - $114.48
52-Week Range $69.11 - $141.58
Volume 1
chart
Top Buy Analysis
BUY: MDVN Rating: 2
Company: MEDIVATION INC.
Points: 195.13
Start Price: $31.37
Start Date: 09/03/2008 8:31 PM
beachdude
beachdude
P&P Score: 95.01
Recs:
Impressive management with great business strategy. good pipeline of new products

Comments: 0 | Comment

Top Sell Analysis
SELL: MDVN Rating: 2
Company: MEDIVATION INC.
Points: -148.77
Start Price: $33.42
Start Date: 12/01/2009 11:18 PM
BearNekkid
BearNekkid
P&P Score: 94.55
Recs:

Comments: 0 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

12 Buy
1 Sell
 
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.99 02/28/14 Market Sells off in the afternoon = High flyers taking a breather 6 02/28/14
zantriocom
0.00 03/16/10 Zantrio.com Free Daily Stock Picks 3-16-2010 0
Neurodoc
99.59 02/03/10 M&M boys up on healthy volume today 4 02/11/10
Zacks_Analysts
0.00 02/15/13 Eylea Drives Regeneron - Analyst Blog 0
Zacks_Analysts
0.00 02/15/13 Eylea Drives Regeneron - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Priority Review for Bayer's Drug - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Priority Review for Bayer's Drug - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Alexion 4Q Tops on Both Lines - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Alexion 4Q Tops on Both Lines - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Priority FDA Review for Celgene Drug - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   ...  14  >>
Commentary
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +399.32
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +397.00
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +396.75
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +399.32
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +397.00
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +396.75
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $34.34
Points: +136.83
Created: 01/23/2010
3 chances to make a significant earnings move and/or be bought

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $34.34
Points: +134.25
Created: 01/23/2010
3 chances to make a significant earnings move and/or be bought

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $34.34
Points: +133.97
Created: 01/23/2010
3 chances to make a significant earnings move and/or be bought

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $34.34
Points: +136.83
Created: 01/23/2010
3 chances to make a significant earnings move and/or be bought

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
Yade 44.99 BUY One to Three Years 11/09/2011 $40.01 $112.31
(-0.72%)
+180.70% +68.97% +111.74 view
Yade 44.99 BUY One to Three Years 11/09/2011 $40.01 $112.31
(-0.72%)
+180.70% +71.26% +109.44 view
Yade 44.99 BUY One to Three Years 11/09/2011 $40.01 $112.31
(-0.72%)
+180.70% +71.50% +109.20 view
Yade 44.99 BUY One to Three Years 11/09/2011 $40.01 $112.31
(-0.72%)
+180.70% +68.97% +111.74 view
Yade 44.99 BUY One to Three Years 11/09/2011 $40.01 $112.31
(-0.72%)
+180.70% +71.26% +109.44 view
Yade 44.99 BUY One to Three Years 11/09/2011 $40.01 $112.31
(-0.72%)
+180.70% +71.50% +109.20 view
COBeeMan 23.87 BUY Week to a Month 09/18/2011 $19.70 $112.31
(-0.72%)
+470.10% +70.79% +399.32 view
COBeeMan 23.87 BUY Week to a Month 09/18/2011 $19.70 $112.31
(-0.72%)
+470.10% +73.11% +397.00 view
COBeeMan 23.87 BUY Week to a Month 09/18/2011 $19.70 $112.31
(-0.72%)
+470.10% +73.35% +396.75 view
COBeeMan 23.87 BUY Week to a Month 09/18/2011 $19.70 $112.31
(-0.72%)
+470.10% +70.79% +399.32 view
Pages: [ 1 ]  2  >>
Sponsored Links